COVID‐19 antibody screening with SARS‐CoV‐2 red cell kodecytes using routine serologic diagnostic platforms

BACKGROUND: The Coronavirus disease 2019 (COVID‐19) pandemic is having a major global impact, and the resultant response in the development of new diagnostics is unprecedented. The detection of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has a role in managing the...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagappan, Radhika, Flegel, Willy A., Srivastava, Kshitij, Williams, Eleanor C., Ryzhov, Ivan, Tuzikov, Alexander, Galanina, Oxana, Shilova, Nadezhda, Sukhikh, Gennady, Perry, Holly, Bovin, Nicolai V., Henry, Stephen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Donor Infectious Disease Testing
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014685/
https://www.ncbi.nlm.nih.gov/pubmed/33590501
http://dx.doi.org/10.1111/trf.16327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014685/
https://www.ncbi.nlm.nih.gov/pubmed/33590501
http://dx.doi.org/10.1111/trf.16327

Ejemplares similares